Back to News
Market Impact: 0.2
Microbot Medical Signs Three-Year Distribution Deal For LIBERTY In Israel
Source: Nasdaq
Healthcare & BiotechProduct LaunchesCompany Fundamentals
Microbot Medical entered a three-year exclusive distribution agreement with Medtechnica Ltd. to market and sell its LIBERTY Endovascular Robotic System in Israel. The announcement provides a commercial distribution channel, but the article gives no financial terms or expected sales impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
MBOT0.55
More News
- GIC Private Ltd, Medline 10% owner, sells over $721m in shares
- A 32% beat, a +6% jump: the IT solutions name our models picked in July
- Nvidia Is on the Verge of a $6 Trillion Market Value
- Controversial $110 billion mega-merger of Paramount and Warner Bros. finally closes
- What Marvell's rosy long-term guidance means for our AI chip stocks
- Analysis-Vietnam’s banks tap investors for $7 billion as economy runs red hot